BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 28864283)

  • 1. Covariation between motor signs and negative symptoms in drug-naive subjects with schizophrenia-spectrum disorders before and after antipsychotic treatment.
    Peralta V; de Jalón EG; Campos MS; Cuesta MJ
    Schizophr Res; 2018 Oct; 200():85-91. PubMed ID: 28864283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DSM-IV catatonia signs and criteria in first-episode, drug-naive, psychotic patients: psychometric validity and response to antipsychotic medication.
    Peralta V; Campos MS; de Jalon EG; Cuesta MJ
    Schizophr Res; 2010 May; 118(1-3):168-75. PubMed ID: 20071147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Motor abnormalities in first-episode psychosis patients and long-term psychosocial functioning.
    Cuesta MJ; García de Jalón E; Campos MS; Moreno-Izco L; Lorente-Omeñaca R; Sánchez-Torres AM; Peralta V
    Schizophr Res; 2018 Oct; 200():97-103. PubMed ID: 28890132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Motor behavior abnormalities in drug-naïve patients with schizophrenia spectrum disorders.
    Peralta V; Campos MS; De Jalón EG; Cuesta MJ
    Mov Disord; 2010 Jun; 25(8):1068-76. PubMed ID: 20222137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurological soft signs in first-episode schizophrenia: State- and trait-related relationships to psychopathology, cognition and antipsychotic medication effects.
    Emsley R; Chiliza B; Asmal L; Kilian S; Riaan Olivier M; Phahladira L; Ojagbemi A; Scheffler F; Carr J; Kidd M; Dazzan P
    Schizophr Res; 2017 Oct; 188():144-150. PubMed ID: 28130002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trajectories of symptom dimensions in short-term response to antipsychotic treatment in patients with a first episode of non-affective psychosis.
    Pelayo-Terán JM; Diaz FJ; Pérez-Iglesias R; Suárez-Pinilla P; Tabarés-Seisdedos R; de León J; Crespo-Facorro B
    Psychol Med; 2014 Jan; 44(1):37-50. PubMed ID: 23461899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pimozide for schizophrenia or related psychoses.
    Mothi M; Sampson S
    Cochrane Database Syst Rev; 2013 Nov; (11):CD001949. PubMed ID: 24194433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of symptoms in neuroleptic-naive patients with schizophrenia and related psychotic disorders before and after treatment.
    Peralta V; Cuesta MJ; Martinez-Larrea A; Serrano JF
    Psychiatry Res; 2001 Dec; 105(1-2):97-105. PubMed ID: 11740979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of second-generation antipsychotic adherence on positive and negative symptoms in recent-onset schizophrenia.
    Subotnik KL; Ventura J; Gretchen-Doorly D; Hellemann GS; Agee ER; Casaus LR; Luo JS; Villa KF; Nuechterlein KH
    Schizophr Res; 2014 Oct; 159(1):95-100. PubMed ID: 25108771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of risperidone versus olanzapine in patients with schizophrenia previously on chronic conventional antipsychotic therapy: a switch study.
    Wang X; Savage R; Borisov A; Rosenberg J; Woolwine B; Tucker M; May R; Feldman J; Nemeroff CB; Miller AH
    J Psychiatr Res; 2006 Oct; 40(7):669-76. PubMed ID: 16762371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of negative symptoms in schizophrenia and schizoaffective disorder by selegiline augmentation of antipsychotic medication. A pilot study examining the role of dopamine.
    Bodkin JA; Cohen BM; Salomon MS; Cannon SE; Zornberg GL; Cole JO
    J Nerv Ment Dis; 1996 May; 184(5):295-301. PubMed ID: 8627275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Responses to antipsychotic therapy among patients with schizophrenia or schizoaffective disorder and either predominant or prominent negative symptoms.
    Stauffer VL; Song G; Kinon BJ; Ascher-Svanum H; Chen L; Feldman PD; Conley RR
    Schizophr Res; 2012 Feb; 134(2-3):195-201. PubMed ID: 22019076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploration of dimensions of psychopathology in neuroleptic-naïve patients with recent-onset schizophrenia/schizophreniform disorder.
    John JP; Khanna S; Thennarasu K; Reddy S
    Psychiatry Res; 2003 Nov; 121(1):11-20. PubMed ID: 14572620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcome after antipsychotic treatment discontinuation in functionally recovered first-episode nonaffective psychosis individuals: a 3-year naturalistic follow-up study.
    Mayoral-van Son J; de la Foz VO; Martinez-Garcia O; Moreno T; Parrilla-Escobar M; Valdizan EM; Crespo-Facorro B
    J Clin Psychiatry; 2016 Apr; 77(4):492-500. PubMed ID: 26759992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study.
    Bobes J; Arango C; Garcia-Garcia M; Rejas J;
    J Clin Psychiatry; 2010 Mar; 71(3):280-6. PubMed ID: 19895779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychological dysfunction in antipsychotic-naive first-episode unipolar psychotic depression.
    Hill SK; Keshavan MS; Thase ME; Sweeney JA
    Am J Psychiatry; 2004 Jun; 161(6):996-1003. PubMed ID: 15169687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal white matter microstructure in drug-naive first episode schizophrenia patients before and after eight weeks of antipsychotic treatment.
    Zeng B; Ardekani BA; Tang Y; Zhang T; Zhao S; Cui H; Fan X; Zhuo K; Li C; Xu Y; Goff DC; Wang J
    Schizophr Res; 2016 Apr; 172(1-3):1-8. PubMed ID: 26852402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder.
    Robinson DG; Woerner MG; Alvir JM; Geisler S; Koreen A; Sheitman B; Chakos M; Mayerhoff D; Bilder R; Goldman R; Lieberman JA
    Am J Psychiatry; 1999 Apr; 156(4):544-9. PubMed ID: 10200732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obstetric complications and neurological abnormalities in neuroleptic-naive psychotic patients.
    Peralta V; Cuesta MJ; Serrano JF
    Eur Arch Psychiatry Clin Neurosci; 2006 Oct; 256(7):407-13. PubMed ID: 16788770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interictal psychoses in comparison with schizophrenia--a prospective study.
    Tadokoro Y; Oshima T; Kanemoto K
    Epilepsia; 2007 Dec; 48(12):2345-51. PubMed ID: 17666070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.